Compare ORN & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORN | FLGT |
|---|---|---|
| Founded | 1994 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 555.4M | 537.6M |
| IPO Year | 2007 | 2016 |
| Metric | ORN | FLGT |
|---|---|---|
| Price | $15.81 | $18.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $16.25 | ★ $28.33 |
| AVG Volume (30 Days) | 336.1K | ★ 388.0K |
| Earning Date | 04-28-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 220.00 | N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $852,260,000.00 | $18,730,000.00 |
| Revenue This Year | $8.50 | $10.09 |
| Revenue Next Year | $7.83 | $12.18 |
| P/E Ratio | $127.58 | ★ N/A |
| Revenue Growth | ★ 7.01 | N/A |
| 52 Week Low | $6.44 | $13.46 |
| 52 Week High | $15.85 | $31.04 |
| Indicator | ORN | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 65.36 | 53.00 |
| Support Level | $13.20 | $13.91 |
| Resistance Level | $15.83 | $19.93 |
| Average True Range (ATR) | 0.74 | 0.79 |
| MACD | 0.15 | -0.16 |
| Stochastic Oscillator | 91.67 | 18.61 |
Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.